SPL Set ID: fea19b14-d8ed-4954-bc54-b9240f78b3c3
1 drug(s) with this SPL Set ID
Divalproex sodium, USP is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure: Divalproex sodium, USP occurs as a white to off-white powder. Divalproex sodium delayed-release capsules, USP are for oral administration. Divalproex sodium delayed-release capsules, USP contain specially coated particles of divalproex sodium, USP equivalent to 125 mg of valproic acid in a hard gelatin capsule. Inactive Ingredients Divalproex sodium delayed-release capsules USP, 125 mg: ethyl cellulose, hypromellose, magnesium stearate, sugar spheres (composed of corn starch, sucrose and water) and triethyl citrate. Hard gelatin capsule shell contains D&C Red No. 28, FD&C Blue No.1, gelatin and titanium dioxide. The capsule shells are printed with edible black ink containing black iron oxide, potassium hydroxide and shellac. Meets USP Dissolution Test 2. divalproex-structure.jpg